Back to School: How biopharma can reboot drug development. Access exclusive analysis here

FDA approves Baxter's Advate Factor VIII

The FDA approved Advate recombinant Factor VIII from BAX to

Read the full 105 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE